tiprankstipranks
Sinco Pharmaceuticals Holdings Ltd. (HK:6833)
:6833
Hong Kong Market
6833
Sinco Pharmaceuticals Holdings Ltd.
RESEARCH TOOLSreports
Want to see HK:6833 full AI Analyst Report?

Sinco Pharmaceuticals Holdings Ltd. (6833) Financial Statements

0 Followers

Sinco Pharmaceuticals Holdings Ltd. Financial Overview

Sinco Pharmaceuticals Holdings Ltd.'s market cap is currently HK$384.22M. The company's EPS TTM is HK$0.015; its P/E ratio is 9.52; and it has a dividend yield of 1.12%. Sinco Pharmaceuticals Holdings Ltd. is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 2.03B¥ 2.82B¥ 2.54B¥ 2.27B¥ 2.02B
Gross Profit¥ 213.34M¥ 299.94M¥ 323.28M¥ 305.87M¥ 364.95M
Operating Income¥ 72.74M¥ 94.94M¥ 108.17M¥ 89.95M¥ 166.39M
EBITDA¥ 97.49M¥ 132.60M¥ 126.01M¥ 109.01M¥ 197.69M
Net Income¥ 33.95M¥ 42.05M¥ 42.35M¥ 69.46M¥ 135.08M
Balance Sheet
Cash & Short-Term Investments¥ 374.53M¥ 308.32M¥ 437.92M¥ 329.14M¥ 326.05M
Total Assets¥ 1.85B¥ 2.00B¥ 1.89B¥ 1.42B¥ 1.23B
Total Debt¥ 183.47M¥ 350.54M¥ 251.40M¥ 192.41M¥ 340.95M
Net Debt¥ -191.07M¥ 42.22M¥ -186.52M¥ -136.73M¥ 14.90M
Total Liabilities¥ 1.15B¥ 1.34B¥ 1.26B¥ 820.52M¥ 857.88M
Stockholders' Equity¥ 694.36M¥ 662.88M¥ 628.05M¥ 603.81M¥ 374.89M
Cash Flow
Free Cash Flow¥ 159.71M¥ -268.05M¥ 289.16M¥ 22.39M¥ 282.19M
Operating Cash Flow¥ 169.49M¥ -232.88M¥ 353.70M¥ 75.08M¥ 305.71M
Investing Cash Flow¥ -27.09M¥ -52.87M¥ -63.63M¥ -119.27M¥ -22.73M
Financing Cash Flow¥ -197.24M¥ 154.59M¥ -189.73M¥ 35.04M¥ -97.11M
Currency in CNY

Sinco Pharmaceuticals Holdings Ltd. Earnings and Revenue History

Income Statement >

Sinco Pharmaceuticals Holdings Ltd. Debt to Assets

Balance Sheet >

Sinco Pharmaceuticals Holdings Ltd. Cash Flow

Cash Flow >

Sinco Pharmaceuticals Holdings Ltd. Forecast EPS vs Actual EPS

Earnings >